58
Participants
Start Date
August 31, 2004
Study Completion Date
August 31, 2005
OSI-7904L
5-Fluorouracil/Leucovorin
Multidisciplinary Oncology Center University Hospital CHUV, Lausanne
Oncology Institute Ion Chiricuta, Cluj-Napoca
Sidney Kimmel Comprehensive Cancer Center, Baltimore
Vanderbilt Cancer Center, Nashville
Division of Hematology/Oncology, Columbus
Tumorforschung Innere Medizinische Klinik, Essen
University of Michigan, Ann Arbor
Wayne State University, Detroit
Robert H. Lurie Comp. Cancer Ctr of Northwestern University, Chicago
Institute Jules Bordet, 1000 Brussels
Dept Internal Medicine Gastrointestinal Oncology Unit, B-3000 Leuven
Department of Gastroenterology and GI Oncology, Brussels
Universitätsklinikum Charite Campus Virchow, 13353 Berlin
Allgemeines Krankenhaus St. Georg, 20099 Hamburg
Klinikum der J. W. Groethe-Universitat, 60590 Frankfurt
Innere Medizin Universitatsklinikum Heidelberg, 69115 Heidelberg
Medizinische Klinik II LMU-Klinikum-Großhadern, 81377 München
Klinika Nowotworow Gornego Odcinka, 02-791 Warszawa
Klinika Chemioterapii, 31-115 Krakow
Institutul Clinic Fundeni, 72437 Bucuresti
Oncosurgery University Hospital of Geneva, 1211 Geneva 14
Lead Sponsor
OSI Pharmaceuticals
INDUSTRY